Atrion International Inc. has announced the successful completion of its REACHexchange™ beta testing program.
Canada - Atrion International Inc. has announced the successful completion of
its REACHexchange™ beta testing program. The results of the beta testing
validated the ease of use and practicality of REACHexchange’s bidirectional
exchange of data between Atrion’s Intelligent Authoring® (IA) application and
local instances of a company’s IUCLID 5 system, the tool for registering
chemical substances under the REACH legislation.
“The European Chemical Bureau’s (ECB) IUCLID 5 license agreement prohibits
companies from directly interfacing a third-party system with IUCLID 5, which
could potentially result in redundant and inconsistent data and in the long run
affect a company’s reputation,” explained Patrick J. Lavoie, President of
Atrion International. “We developed REACHexchange to enable companies to
overcome this limitation, all while working within the confines of the IUCLID 5
Atrion International Completes Beta Testing of REACH Software
July 1, 2008